Back to Search
ROBERT URQUHART, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1952648099Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G10753(CA)
Research & Publications (16)
A prospective study of peri-diagnostic and surgical wait times for patients with presumptive colorectal, lung, or prostate cancer.
PMID 19088720·Br J Cancer·2009
8-other
Are leading medical journals following their own policies on CONSORT reporting?
PMID 18703165·Contemp Clin Trials·2008
8-other
Do available questionnaires measure the communication factors that patients and families consider important at end of life?
PMID 18688055·J Clin Oncol·2008
6-review
Awareness of emergency contraception: a follow-up report.
PMID 18413025·J Fam Plann Reprod Health Care·2008
8-other
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement.
PMID 18361447·Cancer·2008
8-other
Effects of local and core body temperature on grip force modulation during movement-induced load force fluctuations.
PMID 18205008·Eur J Appl Physiol·2008
8-other
2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes.
PMID 18160120·Diabetes Res Clin Pract·2008
3-trial
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.
PMID 16552630·J Pharmacokinet Pharmacodyn·2006
8-other
The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.
PMID 16508777·Diabetologia·2006
4-observational
Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus.
PMID 16026380·Diabet Med·2005
3-trial
Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
PMID 16002175·Diabetes Res Clin Pract·2005
4-observational
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.
PMID 15889234·Diabetologia·2005
3-trial
Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens.
PMID 15739120·Diabetologia·2005
3-trial
Comparison of pioglitazone and gliclazide in sustaining glycemic control over 2 years in patients with type 2 diabetes.
PMID 15735185·Diabetes Care·2005
3-trial
Effects of pioglitazone on the components of diabetic dyslipidaemia: results of double-blind, multicentre, randomised studies.
PMID 15587767·Int J Clin Pract·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1514 LIVE OAK LN
SANTA BARBARA, CA 93105 - Phone
- (805) 886-2848
Quick Facts
- NPI
- 1952648099
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile